Quinoline/thiazole compounds as selective acetylcholinesterase inhibitors: synthesis and biological assessment
Abstract
value of 0.027 ± 0.002 μM. These findings suggest that these novel quinoline/thiazole derivatives could be potential candidates for the development of new therapies for neurodegenerative diseases.
Fields of Study & Subjects
Cholinesterase and Neurodegenerative Diseases
Chemical synthesis and alkaloids
Synthesis and biological activity
Publication details
- Journal / source
- RSC Medicinal Chemistry
- Publisher
- Royal Society of Chemistry (RSC)
- Volume
- 17
- Issue
- 5
- Pages
- 2404–2412
- Publication date
- 1 January 2026
- Language
- EN